Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans
- PMID: 2007320
- DOI: 10.1038/clpt.1991.26
Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans
Abstract
The interaction between digoxin and verapamil was studied in six patients (mean age +/- SD, 61 +/- 5 years) with chronic atrial fibrillation. The effects of adding verapamil (240 mg/day) on steady-state plasma concentrations and renal and biliary clearances of digoxin were studied in a crossover manner. The biliary clearance of digoxin was determined by a duodenal perfusion technique. Verapamil induced a 44% increase in steady-state plasma concentrations of digoxin, from 0.80 +/- 0.24 to 1.15 +/- 0.40 nmol/L (p less than 0.01). The biliary clearance of digoxin decreased by 43%, from 187 +/- 89 to 101 +/- 55 ml/min (p less than 0.05), in the presence of verapamil, whereas the renal clearance was unaffected (153 +/- 31 versus 173 +/- 51 ml/min; difference not significant). Our results indicate that the main inhibitory effect of verapamil on digoxin elimination is on the biliary route.
Similar articles
-
No effect of probenecid on the renal and biliary clearances of digoxin in man.Br J Clin Pharmacol. 1991 Jul;32(1):63-7. doi: 10.1111/j.1365-2125.1991.tb05614.x. Br J Clin Pharmacol. 1991. PMID: 1888643 Free PMC article.
-
Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.Clin Pharmacol Ther. 1990 Jan;47(1):20-6. doi: 10.1038/clpt.1990.3. Clin Pharmacol Ther. 1990. PMID: 2295215
-
Digoxin-verapamil interaction.Clin Pharmacol Ther. 1981 Sep;30(3):311-6. doi: 10.1038/clpt.1981.165. Clin Pharmacol Ther. 1981. PMID: 7273594
-
P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.Pharmacol Res. 1999 Oct;40(4):301-6. doi: 10.1006/phrs.1999.0535. Pharmacol Res. 1999. PMID: 10527640 Review.
-
Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.Vet Hum Toxicol. 1998 Feb;40(1):45-6. Vet Hum Toxicol. 1998. PMID: 9467211 Review.
Cited by
-
Cardiac glycosides. Drug interactions of clinical significance.Drug Saf. 1995 Feb;12(2):97-109. doi: 10.2165/00002018-199512020-00003. Drug Saf. 1995. PMID: 7766341 Review.
-
The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.Br J Clin Pharmacol. 1999 Aug;48(2):180-9. doi: 10.1046/j.1365-2125.1999.00999.x. Br J Clin Pharmacol. 1999. PMID: 10417494 Free PMC article.
-
Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.Drug Saf. 1991 Nov-Dec;6(6):408-30. doi: 10.2165/00002018-199106060-00003. Drug Saf. 1991. PMID: 1793522 Review.
-
Inhibition by basic drugs of digoxin secretion into human bile.Eur J Clin Pharmacol. 1992;42(4):457-9. doi: 10.1007/BF00280136. Eur J Clin Pharmacol. 1992. PMID: 1516611
-
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.Drugs. 1996 May;51(5):792-819. doi: 10.2165/00003495-199651050-00007. Drugs. 1996. PMID: 8861548 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources